7:31 AM ET
8-K
Nasdaq/NYSE Compliance Notice
Cytosorbents Nasdaq/NYSE Compliance Notice
CytoSorbents has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its stock closed at or above that level for 10 consecutive trading sessions. However, the company remains non-compliant with the $35 million Minimum Market Value of Listed Securities (MVLS) requirement and has until December 28, 2026, to resolve this deficiency.
- Counterparty
- Nasdaq
- Term
- until Dec 28, 2026